Please login to the form below

Not currently logged in
Email:
Password:

Flulaval Quadrivalent

This page shows the latest Flulaval Quadrivalent news and features for those working in and with pharma, biotech and healthcare.

China weighs heavy on GSK figures in Q3

China weighs heavy on GSK figures in Q3

Witty emphasised that GSK is entering a new product launch phase with four approvals since the start of the year - including quadrivalent flu vaccine FluLaval and Tyverb (lapatinib) for use alongside

Latest news

  • GSK gets OK for second quadrivalent flu vaccine in US GSK gets OK for second quadrivalent flu vaccine in US

    GSK gets OK for second quadrivalent flu vaccine in US. FDA approves Flulaval Quadrivalent. ... The latest approval is for Flulaval Quadrivalent, which has been given the OK by the FDA for use in patients aged three years or over to protect against A and

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
StratX

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics